Bodhi Tree Biotechnology (BDTB) EBIT Margin (2024 - 2025)
Bodhi Tree Biotechnology (BDTB) reported EBIT Margin of 89.06% for Q3 2025, up 93.13% on a QoQ basis from 1295.54% in Q4 2024.
Bodhi Tree Biotechnology (BDTB) has 2 years of EBIT Margin data on file, last reported at 89.06% in Q3 2025.
- Quarterly EBIT Margin changed N/A year-over-year to 89.06% in Q3 2025, while the trailing twelve-month figure through Dec 2025 was 1131.58% (changed N/A YoY) and the FY2025 annual result came in at 868.34%, down 69133.0% from the prior year.
- EBIT Margin grew to 89.06% in Q3 2025 per BDTB's latest filing, from 1295.54% in the prior quarter.
- Across five years, EBIT Margin topped out at 89.06% in Q3 2025 and bottomed at 1295.54% in Q4 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -89.06% |
| Dec 31, 2024 | -1,295.54% |